4072-2816 Screening compound: 4-[8-(4-methoxyphenyl)-2-(4-pyridyl)furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-9-yl]phenyl methyl ether

4072-2816 Screening compound: 4-[8-(4-methoxyphenyl)-2-(4-pyridyl)furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-9-yl]phenyl methyl ether
4072-2816 Screening compound: 4-[8-(4-methoxyphenyl)-2-(4-pyridyl)furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-9-yl]phenyl methyl ether alternative view

Chemical Structure Depiction of ChemDiv screening compound 4072-2816
4-[8-(4-methoxyphenyl)-2-(4-pyridyl)furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-9-yl]phenyl methyl ether

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4072-2816

Molecular Formula

C26H19N5O3 (C26 H19 N5 O3)

Compound Name

4-[8-(4-methoxyphenyl)-2-(4-pyridyl)furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-9-yl]phenyl methyl ether

IUPAC name

1112-bis(4-methoxyphenyl)-4-(pyridin-4-yl)-10-oxa-3568-tetraazatricyclo[7.3.0.0^{26}]dodeca-1(9)24711-pentaene

SMILES

COc(cc1)ccc1-c1c(-c(cc2)ccc2OC)oc2c1c1nc(-c3ccncc3)nn1cn2

InChI

InChI=1S/C26H19N5O3/c1-32-19-7-3-16(4-8-19)21-22-25-29-24(18-11-13-27-14-12-18)30-31(25)15-28-26(22)34-23(21)17-5-9-20(33-2)10-6-17/h3-15H,1-2H3

InChI Key

FKGWIYHFTUQBQN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03016207

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

449.47

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.921

Distribution Coefficient, logD

4.919

Water Solubility, LogSw

-4.91

Polar Surface Area

62.686

Acid Dissociation Constant (pKa)

33.29

Base Dissociation Constant (pKb)

5.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

7.70

4072-2816 in Drug Discovery

Included in Screening Libraries

ACE2 Library (3043 compounds)

Angiogenesis library (14822 compounds)

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 4072-2816 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 4072-2816?
Check Price and Availability of 4072-2816, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 4072-2816 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 4072-2816
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 4072-2816
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 4072-2816 available by request